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ABSTRACT 
 
Cataract surgery is the most frequently performed surgical procedure worldwide. We aim to determine the 
prevalence of having implanted an artificial lens (pseudophakia) and of no lens (aphakia) and to compare visual 
function.  
As part of the Gutenberg Health study, a population-based cross-sectional study was conducted in Germany. An 
ophthalmological examination including slit-lamp examination was conducted. Prevalence including 95% 
confidential intervals were calculated and analyses were conducted for systemic and ocular associated factors 
with pseudophakia using multivariable logistic regression models. Vision-related quality of life was assessed 
using a standardized questionnaire and Rasch transformation. 
14,696 people were included. Of these, 1.55% [1.36%–1.77%] had unilateral pseudophakia and 3.08% [2.81%-
3.37%] had bilateral pseudophakia. Unilateral aphakia was present in 21 people and bilateral aphakia in 2 
people. Pseudophakia was independently associated with age, higher body weight and lower body height, 
diabetes and smoking. Vision-related quality of life values were similar for those with bilateral phakia and 
pseudophakia but were lower for those with unilateral pseudophakia. 
The pseudophakia status is related to several cardiovascular risk factors, indicating a relationship to an aging 
effect that causes premature lens opacification. Bilateral pseudophakia can almost imitate the physiological 
condition of phakia except for the need to use glasses. 
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INTRODUCTION 
 
Cataract has been identified as the leading cause of 
visual impairment and blindness worldwide [1]. 
Cataract surgery is the most frequently performed 
surgical procedure worldwide. The opacified lens is 
removed and either replaced with an artificial 
intraocular lens (pseudophakia), or the resulting 
refractive error is corrected with spectacles or with 
contact lenses in cases of aphakia. 
 
While the frequency and outcome of cataract surgery in 
developing countries is well investigated [2-10], the 
prevalence of pseudophakia or aphakia in high income 
countries is less well investigated at present [11-14]. 
During the last two decades, several technological 
improvements have made cataract surgery a relatively 
safe and common procedure. Even clear lens extractions 
are performed during refractive surgery [15].  
 
In the Gutenberg Health Study we had the opportunity 
to investigate the prevalence of pseudophakia and 
aphakia in Germany and to evaluate associated factors. 
Furthermore, we investigated vision-related quality of 
life and tested the hypothesis whether vision-related 
quality of life in persons with pseudophakia is different 
compared to bilateral phakic people. 
RESULTS 
 
A total of 14,696 study subjects were included in this 
analysis. Detailed descriptions of the study sample 
characteristics are provided in Table 1. Data for 314 
people (2%) were missing.  
 
Prevalence of pseudophakia and aphakia 
 
Two hundred twenty-eight people of the study 
population (1.55%; 95% confidence interval [1.36%-
1.77%]) had unilateral pseudophakia, while 452 (3.08% 
[2.81%-3.37%]) had bilateral pseudophakia. Unilateral 
aphakia was present in 21 people (0.14% [0.09%-
0.22%]), and bilateral aphakia was present in 2 people 
(0.01% [0.00%-0.05%]). The prevalence data for each 
decade of age is given in Figure 1 showing no age 
dependency. 
 
The weighted prevalence data for Germany for people 
aged 35 to 74 years are 1.36% [1.18% - 1.57%] for 
unilateral pseudophakia and 2.64% [2.39% - 2.91%] for 
bilateral pseudophakia. Unilateral aphakia was present 
in 0.14% [0.09% - 0.21%], and bilateral aphakia was 
present in 0.01% [0.00% - 0.05%]. The prevalence data 
are described separately for each decade of age and for 
each sex in Figure 2.  
 
 
Figure 1. Age-specific prevalence and 95% confidence intervals for aphakia (in percentages) in 35- to 74-year-old 
people in Germany (the Gutenberg Health Study).  
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Table 1. Characteristics of the baseline sample of the German population-based Gutenberg Health Study (GHS), 
2007-2012, stratified according to eye status (bilateral phakic persons, unilateral pseudophakia and bilateral 
pseudophakia). 
Subjects: Bilateral phakic persons (13993)  
Unilateral pseudophakia 
(228)  
Bilateral pseudophakia 
(452)  
Sex (Women)  49.4% (6918)  51.3% (117)  52.4% (237)  
Age [y]  54.0 (45.0/64.0)  68.0 (63.0/72.0)  70.0 (65.0/72.0)  
SES (median and interquartile-range) 13.00 (9.00/17.00)  11.00  (8.00/15.00)  
10.00  
(8.00/13.33)  
Residence (rural)  46.5% (6506)  52.2% (119)  48.9% (221)  
Cardiovascular 
Risk factors:     
Diabetes (yes) 1 8.7% (1216)  17.1% (39)  24.5% (110)  
Obesity (yes) 2 24.7% (3452)  29.4% (67)  39.2% (177)  
Smoking (yes) 19.8% (2762)  9.7% (22)  14.0% (63)  
Hypertension (yes) 3 48.6% (6797)  64.5% (147)  72.1% (326)  
Dyslipidemia (yes) 4 34.1% (4761)  43.2% (98)  47.9% (216)  
FH of MI/Stroke (yes) 5 22.0% (3076)  22.4% (51)  25.4% (115)  
Anthropometry:     
BMI [kg/m²]  27.3±5.0  28.1±4.7  29.1±5.2  
Weight [kg]  79.7±16.6  78.5±15.4  81.0±15.8  
Height [cm]  171±9  167±10  167±9  
Waist [cm]  94.3±13.9  97.3±13.4  100.0±13.8  
Hip [cm]  102.0±9.9  102.6±9.1  104.1±10.5  
WHR  0.924±0.092  0.947±0.090  0.960±0.088  
Lipids:     
Cholesterol [mmol/l]  221±41  224±38  220±44  
HDL [mg/dl]  57.3±15.6  60.0±17.4  57.3±16.7  
LDL [mg/dl]  139±36  140±33  138±37  
Triglycerides [mg/dl]  105.0 (78.0/147.0)  104.2 (79.2/140.0)  114.0 (83.0/159.0)  
Ophthalmic parameters:   
Pseudophakic/  
phakic eyes  
Glasses (yes)  88.8% (12431)  96.5% (220)  97.8% (442)  
Distance glasses (yes)  67.2% (9402)  81.6% (186)  68.8% (311)  
Contact lenses (yes)  4.7% (651)  1.3% (3)  0% (0)  
Reading glasses (yes) 71.8% (10049) 95.2% (217) 92.9% (420) 
Intraocular pressure [mmHg]  14.3±2.8  14.0±2.8  14.0±3.3  
Central corneal thickness [µm]  554±35  555±35  553±37  
Refraction: 
Sphere [dpt]  -0.123±2.433  
-0.63±1.38 /  
-0.28±2.83  -0.500±1.165  
Cylinder [dpt]  
in median (interquartile-range) -0.375 (-0.750/-0.125)  
 -0.75 (-1.21/-0.50)  
/ -0.50 (-1.00/-0.25)  -0.625 (-1.000/-0.375)  
Visual acuity [logMAR] 0.07±0.12 0.24±0.28/ 0.22±0.27 0.16±0.17 
www.aging-us.com 1033 AGING  
Cataract as determined by slit-lamp 
examination 31.1% (4348) 70.6% (161) Not applicable 
Eye diseases (self-reported):    
Glaucoma (yes)  2.0% (275)  10.5% (24)  7.3% (33)  
AMD (yes)  0.4% (56)  2.2% (5)  1.5% (7)  
Corneal disease (yes)  1.9% (263)  4.8% (11)  4.0% (18)  
Means ± standard deviation are reported for normally distributed data, absolute and relative frequency are reported for 
dichotomous variables, and medians and quartile ranges are reported otherwise. Abbreviations: (AMD: age-related macular 
degeneration; BMI: body mass index; FH: family history; HDL: high-density lipoproteins; LDL: low-density lipoproteins; MI: 
myocardial infarction; SES: socio-economic status; WHR: waist-hip ratio; 1 HBA1C ≥ 6.5 or diabetic medication use or diagnosis 
by physician; 2 BMI ≥ 30 kg/m2; 3 hypertension diagnosed by a physician or systolic blood pressure ≥ 140 mmHg or diastolic 
blood pressure ≥ 90 mmHg or anti-hypertensive medication; 4 LDL/HDL ratio >3.5 or lipid-lowering medication use; 5 Family 
history of myocardial infarction or family history of stroke.) 
 
 
Reasons for aphakia 
 
The reasons for unilateral aphakia were eye injury (11 
people), unilateral congenital cataract (1 person), high 
myopia (1 person), recurrent uveitis (1 person) and 
unknown (7 people). Bilateral congenital cataract was 
the cause of bilateral aphakia in one person, while the 
other person had a perforating injury in one eye and 
later developed a complicated retinal detachment in the 
other eye. 
 
Of the 228 people with unilateral pseudophakia, one 
had an iris-fixated anterior chamber intraocular lens 
following phakic lens removal because of an eye 
trauma, and one person had a chamber-angle-supported 
intraocular lens following unilateral cataract surgery in 
childhood. 
 
Of the 452 people with bilateral pseudophakia, one had 
a secondary implantation of an iris-fixated anterior 
chamber intraocular lens after endophthalmitis, and one 
had an iris-fixated anterior chamber intraocular lens in 
addition to a posterior chamber intraocular lens. 
 
Characteristics of pseudophakic persons 
 
Logistic regression analyses showed that higher age, 
higher body weight, smaller body height, diabetes and 
smoking were independently associated with presence 
of any pseudophakia (unilateral or bilateral; Table 2).  
 
 
Figure 2. Age- and sex-specific prevalence and 95% confidence intervals for pseudophakia (in percentages) in 35- to 
74-year-old people in Germany (the Gutenberg Health Study).  
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For unilateral pseudophakia, higher age and lower body 
height were independently associated, while for 
bilateral pseudophakia, higher age and smoking status 
were independently associated (Table 2). 
 
Self-reported eye diseases were more common in 
people with unilateral pseudophakia compared with 
those with bilateral pseudophakia or phakic persons.  
 
Among those with unilateral pseudophakia, 10.5% 
reported having glaucoma, compared with 7.3% of 
people with bilateral pseudophakia and 2.0% of phakic 
people. While the presence of age-related macular 
degeneration was similar in all three groups, corneal 
diseases were more common in people with unilateral 
pseudophakia (Table 1). Cataracts were found on slit-
lamp examination in 31% of the bilateral phakic 
participants, while 71% of those with unilateral 
pseudophakia had a cataract in the other eye 
 
Visual function and vision-related quality of life 
 
Distance-corrected visual acuity differed between the 
three groups: phakic people showed the best mean 
visual acuity (logMAR: 0.07±0.12), followed by those 
with bilateral pseudophakia (logMAR: 0.16±0.17) and 
those with unilateral pseudophakia (phakic eyes: 
0.22±0.27, pseudophakic eyes: 0.24±0.28).  
 
Vision-related quality of life data, in terms of Rasch 
transformed scales of the NEI VFQ-25 values, are 
provided in Table 3. The people with bilateral phakia 
had the highest scores for socioemotional scale and 
visual function scale. followed by those with bilateral 
pseudophakia, while the people with unilateral 
pseudophakia had the lowest scores.  
 
After the age- and sex-standardization of vision-related 
quality of life in people aged 60 years and more, the 
quality of life of those with bilateral pseudophakia was 
comparable to that of the people with bilateral phakia in 
the visual function scale, while the people with 
unilateral pseudophakia had reduced vision-related 
quality of life measurements (Table 4). 
 
Using glasses 
 
The use of glasses for distance vision was higher in the 
unilateral pseudophakic group (82%) than in the 
bilateral groups (pseudophakic: 69%; phakic 67%). For 
Table 2. Analysis of anthropometric and cardiovascular associations with pseudophakia versus phakia as the 
lens status using a logistic regression model in 35- to 74-year-old people in Germany (the Gutenberg Health 
Study). 
   
  
 
Any pseudophakia vs.  
bilateral phakic persons 
(14380 persons) 
Unilateral pseudophakia vs. 
bilateral phakic persons  
(13938 persons) 
Bilateral pseudophakia vs. 
bilateral phakic persons  
(14157 persons) 
 OR  
Lower 
95%C
I 
Upper 
95%C
I  
p-value  OR  
Lower 
95%C
I 
Upper 
95%C
I  
p-value  OR  
Lower 
95%C
I 
Upper 
95%C
I  
p-value  
              
Sex (Women) 1.05 0.82 1.35 0.70 0.83 0.55 1.26 0.38 1.19 0.773 2.117 0.27 
Age [10y] 4.51 3.96 5.15 < 0.0001 3.43 2.77 4.19 < 0.0001 5.36 4.53 6.39 0.00032 
SES 1.01 0.99 1.03 0.33 1.03 1.00 1.06 0.09 1.00 0.98 1.02 0.97 
Weight [kg]  1.01 1.00 1.02 0.005 1.01 0.99 1.02 0.43 1.01 1.00 1.02 0.0023 
Height [cm]  0.98 0.97 0.99 0.005 0.97 0.95 1.00 0.028 0.98 0.96 1.00 0.032 
Diabetes  1.40 1.12 1.74 0.003 1.16 0.77 1.71 0.47 1.50 1.16 1.94 0.0021 
Smoking  1.30 1.01 1.70 0.039 0.85 0.52 1.33 0.50 1.60 1.19 2.13 0.0016 
HDL [mg/dl]  1.00 1.00 1.00 0.63 1.01 1.00 1.02 0.25 1.00 0.99 1.01 0.85 
LDL [mg/dl]  1.00 1.00 1.00 0.36 1.00 1.00 1.00 0.72 1.00 1.00 1.00 0.42 
Triglycerides 
[mg/dl] 1.00 1.00 1.00 0.052 1.00 1.00 1.00 0.13 1.00 1.00 1.00 0.15 
Abbreviations: OR: odds ratio; 95%CI: 95% confidence interval; SES: socio-economic status. 
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reading purpose, 72% of the bilateral phakic persons 
stated using glasses, compared to 95% of those with 
unilateral and 93% of those with bilateral pseudophakia. 
When incorporating age and sex differences, 79% of 
bilateral phakic persons and only 69% of persons with 
bilateral pseudophakia reported using glasses for 
distance vision (both values refer to people over 60 
years old). Glasses for reading were used in similar 
proportions (97% of bilateral phakic people, 96% of 
those with unilateral pseudophakia and 93% of those 
with bilateral pseudophakia). 
 
Intra-individual comparison 
 
When we analyzed the characteristics of the 
pseudophakic versus the phakic eye of the same 
participants (228 people), we found greater astigmatism 
in the pseudophakic eye (median -0.50 diopters (25%-
/75%-quartile -1.00/-0.25) versus -0.75 diopters (-1.21/-
0.50), p-value 0.008), while spherical refraction (-0.28 
+/- 2.83 vs. -0.63 +/- 1.38 diopters) and distance-
corrected visual acuity (phakic eyes: 0.22±0.27, 
pseudophakic eyes: 0.24±0.28 in logMAR) did not 
differ. 
 
DISCUSSION 
 
For the first time, we report the prevalence of 
pseudophakia and aphakia in Germany in a population 
based study and investigate the causes of aphakia after 
the introduction of phacoemulsification and the 
implantation of a posterior-chamber intraocular lens. 
We found that 1.55% of the 35- to 74-year-old 
population has unilateral pseudophakia, and 
approximately 3% has bilateral pseudophakia. These 
people are more likely to be older, to suffer from 
diabetes and to smoke. Sex is not associated with 
pseudophakia status.  
 
Prevalence of pseudophakia and associated factors 
 
The prevalence of pseudophakia in our cohort is similar 
to that reported in other regions of the world: e.g., the 
Singapore Malay Eye Study (4.7%) [4], the Beaver 
Dam Eye Study in Wisconsin (3.1%) [16], the 
Australian Blue Mountains Eye Study (6.0%) [17], the 
Barbados Eye Study (3.0%) [18] and the Central India 
Eye and Medical Study (5.0%) [7]; however, other 
Indian studies of urban regions have reported figures as 
high as 9.4% [9,19]. In China, the prevalence of 
pseudophakia is lower, as reported in the Beijing Eye 
Study 2006 [20] and 2009 [5] and the China Nine-
Province Survey [10]. Because these prevalence data 
are not standardized to the same age and sex 
distribution, they are not directly comparable. In 
addition, most of the studies did not distinguish between 
unilateral and bilateral pseudophakia. When comparing 
changes in lens extractions over time, the Beaver Dam 
Eye Study found a remarkable 6.5-fold increased 
incidence between 1990 and 2010 [21]. 
Table 3. Descriptive of vision-related quality of life measured by the NEI VFQ-25 questionnaire in persons 
with phakic lenses or pseudophakia in 35-74 year old persons in Germany (the Gutenberg Health Study).  
Mean±SD Bilateral phakic persons (13993) 
Unilateral pseudophakia 
(228) 
Bilateral pseudophakia 
(452) 
Long form visual function scale 
(LFVFS) 86.8±10.6 78.6±15.3 84.1±12.1 
Long form socioemotional scale 
(LFSES) 96.2±7.3 90.3±14.1 93.5±9.8 
Visual function scale and socioemotional scale in long form was calculated using Rasch analysis. 
 
Table 4.  Age- and sex-standardized vision-related quality of life measured by the NEI VFQ-25 questionnaire 
in persons with phakic lenses or pseudophakia in persons above 60 years in Germany (the Gutenberg 
Health Study).  
Mean±SD Bilateral phakic persons  Unilateral pseudophakia Bilateral pseudophakia 
Long form visual function scale (LFVFS) 85.1±11.0 79.3±15.4 84.9±11.6 
Long form socioemotional scale (LFSES) 95.1±8.3 90.9±14.3 93.8±9.5 
Visual function scale and socioemotional scale in long form was calculated using Rasch analysis. 
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As in the Central India Eye and Medical Study and the 
Tanjong Pagar Survey from Singapore [22], diabetes 
mellitus was independently associated with having had 
cataract surgery. It is not clear whether diabetic subjects 
were referred to an ophthalmologist earlier to screen for 
diabetic retinopathy. If so, decreased vision would have 
been detected earlier; however, it is more likely that 
diabetes is a risk factor for cataract [23] and therefore, 
diabetic people are more likely to have had cataract 
surgery. Nevertheless, cataract and diabetic retinopathy 
is both linked to an aging organism. Similarly, the 
presence of a pseudophakic intraocular lens was related 
to smoking status, which is a known risk factor for 
cataract formation [24].  
 
In the multivariable analysis in the present study, 
pseudophakia was independently associated with a 
heavier body weight and a shorter body height. A recent 
meta-analysis of cohort studies showed that age-related 
cataract is associated with obesity [25], while a lower 
body height was associated with cataract in the 
Physicians' Health Study [26]. Socioeconomic status 
was independent of the presence of pseudophakia, 
which is not surprising for a country with a health 
insurance system that covers almost 100 percent of the 
population and reimburses the costs of cataract surgery 
with intraocular lens implantation. 
 
The standardized prevalence of aphakia is lower in the 
German population than reported for other study 
populations in developed countries or regions [5,11,27]. 
The cause of aphakia in our study population was 
primarily trauma and aphakia in Germany can be 
considered as individual cases. 
 
Visual acuity and vision-related quality of life 
 
Visual function differed between the participants with 
bilateral phakia, unilateral pseudophakia and bilateral 
pseudophakia. Distance-corrected visual acuity was 
normal in the bilateral phakic participants and was 
almost normal in the subjects with bilateral 
pseudophakia. In subjects with unilateral pseudophakia, 
visual acuity did not differ between the phakic and the 
pseudophakic eye but was lower compared with phakic 
subjects or with subjects having bilateral pseudophakia. 
 
Vision-related quality of life was highest in bilateral 
phakic participants in our study cohort, followed by the 
bilateral pseudophakic group and the unilateral 
pseudophakic group. When incorporating age- and sex-
standardization, the bilateral phakic and pseudophakic 
groups were comparable: the unidimensional score 
“visual function scale” was almost identical. This 
indicates that bilateral pseudophakia permits a visual 
quality of life that is very similar to the physiological 
condition. Our finding of lower vision-related quality of 
life in subjects with unilateral pseudophakia than in 
those with bilateral pseudophakia is in agreement with 
previous work by Javitt et al. [28]. Javitt et al. reported 
that patients who underwent surgery in both eyes had 
greater improvement in vision-related quality of life 
than did those who underwent surgery in only one eye. 
They concluded that there seems to be a beneficial 
restoration of binocular vision when both eyes are 
treated. Similarly, To et al. showed that the increase in 
vision-related quality of life after bilateral cataract 
surgery is related to an improved stereopsis and contrast 
sensitivity and not to visual acuity [29]. In addition, 
brightness and color perception increases when 
replacing an opacified lens with a clear implant. The 
causes for lower visual acuity and lower vision-related 
quality of life in peoples with unilateral pseudophakia 
might be the higher proportion of eye diseases in these 
people in our study: we found an increase in self-
reported glaucoma and corneal diseases among those 
with unilateral pseudophakia compared with those with 
bilateral pseudophakia and with bilateral phakic 
persons. Similar results were found for the presence of 
cataract: over 70% of subjects with unilateral 
pseudophakia had a cataract in the other eye. 
 
Using glasses 
 
As suspected, cataract surgery with intraocular lens 
implantation leads to a need for glasses when 
monofocal intraocular lenses are implanted, as is the 
standard treatment covered by health insurance in 
Germany. In our study cohort, 98% of the study 
participants over the age of 60 years reported wearing 
glasses either for distance or near vision. Further 
analysis showed that bilateral pseudophakia is linked to 
less need to wear glasses for distance vision (69% for 
bilateral pseudophakia vs. 79% for bilateral phakia vs. 
82% for unilateral pseudophakia), while the proportions 
of persons using reading glasses were comparable 
between each lens status group. However, it is to be 
noted that the primary goal of cataract surgery is 
replacing the opacified crystalline lens by a clear 
implant, not to correct refractive errors. 
 
When comparing the pseudophakic eye with the phakic 
eye in the same person, we did detect a higher rate of 
astigmatism in the pseudophakic eye (0.25 diopters) but 
no difference in sphere. Cataract surgery may introduce 
the degree of corneal astigmatism [30]. 
 
There are methodological limitations to the study: first, 
the pseudophakic and aphakic status was determined by 
slit-lamp examination using an undilated pupil. Because 
most of our study participants were Caucasians, our 
conclusions should be considered valid for this ethnicity 
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only and cannot be generally applied to people from 
other ethnic and genetic backgrounds. In addition, the 
age range of our study population was 35 to 74 years; 
therefore, the prevalence data are only valid for this age 
range and there may be a further increase of prevalence 
towards the very old persons. Response to study 
invitation has to be considered as limitation in most 
population-based studies. In our study, the response was 
60% [31]. As we do not have any knowledge about eye 
health in non-responders, we are not able to adjust for 
that people with low vision might be less likely to 
participate. Regarding differences in response within 
our study population, persons with an age between 35 
and 44 years showed a lower, but similar response for 
men and women [32]. As prevalence of pseudophakia is 
very low before the age of 50 years due to the rare 
condition of early cataract development, this will rather 
not have influenced our results. In addition, women 
over the age of 65 years did less likely participate in our 
study than did men in this age or younger persons. As 
we found a comparable increase of prevalence of 
pseudophakia between men and women towards older 
age, the smaller response of older women is rather 
unlikely to have distorted our results. 
 
In summary, the prevalence of pseudophakia ranges 
from 0.2% in the 35- to 44-year age group to 13.4% in 
the 65- to 74-year age group in Germany. The 
pseudophakia status is related to several cardiovascular 
risk factors, indicating a relationship with aging 
mechanisms that caused premature lens opacification 
that was treated with cataract surgery. Vision-related 
quality of life measurements indicate that bilateral 
pseudophakia can almost imitate the physiological 
condition of phakia except for the need to use glasses. 
Aphakia is currently a rare condition in Germany and is 
primarily caused by trauma or the consequence of 
congenital cataract. 
 
METHODS 
 
The Gutenberg Health Study (GHS) is a prospective, 
population-based, observational cohort study conducted 
in the Rhine-Main region in Germany. Our sample of 
15,010 participants was randomly drawn from local 
governmental registry offices. The cohort was equally 
stratified by sex, urban and rural residence within each 
decade of age. More details regarding the study design 
are described in Höhn et al. [31]. For each participant, a 
comprehensive ophthalmological examination was 
conducted. Objective refraction (Humphrey Automated 
Refractor/Keratometer (HARK) 599, Carl Zeiss 
Meditec AG, Jena, Germany) and distance-corrected 
visual acuity, non-contact tonometry (Nidek NT-2000, 
Nidek Co, Japan), slit-lamp examination of the anterior 
segment and funduscopy was performed, and 
ophthalmic conditions (e.g., phakia, pseudophakia and 
aphakia) were documented using standardized 
documentation sheets. These variables (aphakia, 
pseudophakia) were validated using refraction and the 
ophthalmic medical history.  
 
Venous blood was collected during the fasting state 
(i.e., overnight fasting if the subject was examined 
before 12 p.m. and 5-hour fasting if the subject was 
examined after 12 p.m.). Diabetes mellitus was 
determined in individuals with HbA1c ≥6.5%, those 
who were taking diabetic medication and those who had 
been diagnosed by a physician. 
 
The subjects’ socioeconomic status (SES) was defined 
according to the SES index used for the German Health 
Update 2009 (GEDA) and ranged from 3 to 21.[33]  
 
Vision-related quality of life was assessed using the 
German version of the National Eye Institute 25-Item 
Visual Function Questionnaire (NEI VFQ-25) [34,35]. 
The questionnaire was self-administered as print-out. 
The data were extracted by study staff using double-
entry to ensure data quality. The NEI VFQ-25 consists 
of 25 questions that are originally used to calculate 
twelve subscores and one global vision-related quality 
of life (QoL) score, with values ranging from 0=worst 
to 100=best. Previous studies showed that these scores 
underlie multidimensionality [36-38].  
 
We therefore chose a Rasch-based analyse, as 
conducted by several studies [39-41]. Rasch analysis 
enables to transform the raw questionnaire data into an 
interval-level scale. We utilized the transformation 
algorithm as suggested by Pesudovs et al. [39]. The 
polarity of several items was adapted to ensure that a 
higher score corresponds to lower performance. The 
answer option “Stopped doing this for other reasons or 
not interested in doing this” was set to missing. The 
filter question 15 (“Are you currently driving, at least 
once in a while?”) and the related questions 15a and 15b 
were excluded. The tables provided by Pesudovs et al. 
[39] were utilized to assign for each question the raw 
measures to Rasch-transformed scores on person-level. 
Based on these measures, the visual function scale (long 
form: LFVFS) and the socioemotional scale (long form: 
LFSES), were calculated [39]. For the LFVFS, the 
Rasch-transformed scores of questions 2, 5, 6, 7, 8, 9, 
10, and 14 were add up and transformed to a scale of 0 
to 100, where 0 corresponds to worst performance, and 
that 100 corresponds to the sum of all items answered 
with the least reduction in performance. Analogue, the 
scores of LFSES (questions 11, 13, 17, 18, 20, 21, 22, 
23, 24, 25) have been calculated. 
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Informed consent 
 
The study protocol and study documents were approved 
by the local ethics committee of the Medical Chamber 
of Rhineland-Palatinate, Germany (reference no. 
837.020.07; original vote: 22.3.2007, latest update: 
20.10.2015). According to the tenets of the Declaration 
of Helsinki, written informed consent was obtained 
from all participants prior to entering them in the study. 
 
Study sample 
 
This study comprised the baseline examination of the 
GHS and included subjects who were aged 35 to 74 
years at the time of examination. The examinations took 
place between April 2007 and March 2011. There was 
no exclusion criterion.  
 
Data and statistical analysis 
 
All primary and secondary variables were first tested for 
normal distribution. Medians, interquartile ranges, 
minimums and maximums were calculated for all 
primary and secondary variables. For variables that 
were normally distributed, means and standard 
deviations were computed as well.  
 
First, age-specific prevalence of pseudophakia and 
aphakia were calculated. To estimate the overall 
standardized prevalence, the age/sex-distribution of the 
the German population from the year 2014 was used 
[42]. Associated anthropometric and cardiovascular 
factors were evaluated using multivariable logistic 
regression models. Models comparing #1 people with 
any pseudophakia to people without lens replacement, 
#2 people with unilateral pseudophakia (and phakia in 
the fellow eye) to those with bilateral phakia (i.e., 
without lens replacement), #3 people with bilateral 
pseudophakia to people with bilateral phakia were 
analyzed. The included covariables were sex, age (as 
continuous variable), SES, body weight, body height, 
diabetes, smoking and concentration of lipids (high-
density lipoproteins, low-density lipoproteins, 
triglycerides). 
 
An intra-individual comparison (pseudophakic versus 
phakic eye) using a paired t-test was performed to 
evaluate differences in refraction (sphere, astigmatism) 
and visual acuity. 
 
Vision-related quality of life were analyzed descrip-
tively. Age- and sex-standardization of vision-related 
quality of life and wearing spectacles in people aged of 
60 years and more was performed to compare these 
variables between people with unilateral pseudophakia, 
bilateral pseudophakia and bilateral phakia.  
The data were processed using statistical analysis 
software (R version 3.1.1 [2014-07-10]). 
 
This study was performed as an explorative study to 
analyze the prevalence of pseudophakia and aphakia 
and the factors associated with these conditions. All p-
values should be regarded as continuous parameters that 
reflect the level of evidence and are therefore reported 
exactly. 
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